KLF9 and cancer: KLF9-bound genomic regions, along with those of SP1, CTCF, NRF1, GABPA, and YY1, were found to exhibit resistance to de novomethylation in cancers, likely due to their role in maintaining open chromatin or recruiting epigenetic modifiers.